ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St futures rise as Fed rate hike lifts long-standing overhang
- Oil prices extend losses as supply disruption fears ease
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
ResMed (RMD) Tops Q4 EPS by 1c, Revenues Beat
July 25, 2019 4:27 PM EDTResMed (NYSE: RMD) reported Q4 EPS of $0.95, $0.01 better than the analyst estimate of $0.94. Revenue for the quarter came in at $705 million versus the consensus estimate of $702.28 million.
Fourth Quarter 2019 Highlights
Revenue increased 13% to $705.0 million; up 15% on a constant currency basisGross margin expanded 120 bps... More